Skip to main content
Clinical Trials/ISRCTN40582975
ISRCTN40582975
Active, not recruiting
未知

Prevention of progression to type 2 diabetes in women with gestational diabetes: A feasibility study for a randomised trial on a Mediterranean diet

Queen Mary University of London0 sites83 target enrollmentMay 15, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Gestational diabetes
Sponsor
Queen Mary University of London
Enrollment
83
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 15, 2019
End Date
March 1, 2021
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Women diagnosed with gestational diabetes as per the National Institute for Health and Care Excellence (NICE) criteria at time of consent and who are treated with metformin and/or insulin in pregnancy.
  • 2\. Aged 16 years or over at the time of consent.
  • 3\. Able and willing to follow a Mediterranean diet until 1 year after childbirth.
  • 4\. Smartphone user

Exclusion Criteria

  • 1\. Unable to provide written informed consent in English
  • 2\. Diagnosed with pre\-existing type 1 or type 2 diabetes
  • 3\. Body Mass Index of \<\= 18\.5 kg/m2 or \>\= 50 kg/m2
  • 4\. Allergic to nuts
  • 5\. Concomitant participation in:
  • \-another dietary interventional study during pregnancy;
  • \-another interventional study in the postnatal period

Outcomes

Primary Outcomes

Not specified

Similar Trials